We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Lymphocyte counts predict optimal timing of chemotherapy reinitiation after antivirus treatment for herpes zoster in children with leukemia

    Herpes zoster (HZ) is rare in healthy children, but more prevalent in those with leukemia. Optimal timing of chemotherapy reinitiation after HZ...

    Xuanlu Zhang, Ye Feng, ... **aoming Bai in Archives of Dermatological Research
    Article 01 June 2024
  2. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer

    Background

    A growing body of research indicates that poor functional status before chemotherapy may be correlated with the severity of...

    Kuan-Yin Lin, Po See Chen, Cheng-Feng Lin in BMC Gastroenterology
    Article Open access 06 May 2024
  3. Changes in skeletal muscle function during chemotherapy and related factors in patients with acute leukemia

    Introduction

    Skeletal muscle function is an important prognostically relevant indicator in patients with acute leukemia (AL), but skeletal dysfunction...

    Yusuke Terao, Yasuhide Nakayama, ... Minoru Yamada in Supportive Care in Cancer
    Article 13 July 2024
  4. Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI

    Objectives

    Early diagnosis of chemotherapy-induced cardiotoxicity plays an important role in preventing heart failure. The main aim of our study was...

    Siamak Derakhshan, Bayazid Ghaderi, Daem Roshani in Annals of Nuclear Medicine
    Article 20 January 2024
  5. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study

    Background

    Adjuvant chemotherapy (AC) improves the prognosis after pancreatic ductal adenocarcinoma (PDAC) resection. However, previous studies have...

    Charles Poiraud, Xavier Lenne, ... Mehdi El Amrani in World Journal of Surgical Oncology
    Article Open access 06 May 2024
  6. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer

    Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for patients with localized pancreatic cancer. Upfront surgery...

    Thomas F. Stoop, Rutger T. Theijse, ... Marc G. Besselink in Nature Reviews Gastroenterology & Hepatology
    Article 30 November 2023
  7. Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancer

    Purpose

    Automated scalp cooling (ASC) is available to patients undergoing chemotherapy for breast cancer to decrease chemotherapy-induced alopecia....

    Benjamin E. Ueberroth, Heidi E. Kosiorek, ... Donald W. Northfelt in Supportive Care in Cancer
    Article 06 June 2024
  8. Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer

    Background

    The benefits of chemotherapy in stage II colon cancer remain unclear, but it is recommended for high-risk stage II disease. Which patients...

    Meridith C. Ginesi, Jonathan T. Bliggenstorfer, ... Emily F. Steinhagen in Annals of Surgical Oncology
    Article 30 May 2023
  9. Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma

    Background

    A post-hoc analysis of ABC trials included 34 patients with liver-confined unresectable intrahepatic cholangiocarcinoma (iCCA) who received...

    Stijn Franssen, Jessica J. Holster, ... Bas Groot Koerkamp in Annals of Surgical Oncology
    Article Open access 09 October 2023
  10. Complete reduction surgery of a huge recurrent adult granulosa cell tumor after neoadjuvant chemotherapy

    Adult granulosa cell tumors are rare, accounting for only 3–5% of all ovarian tumors. Adult granulosa cell tumors have late recurrences, for which...

    Hiroha Tokui, Hideaki Yahata, ... Kiyoko Kato in International Cancer Conference Journal
    Article 14 February 2024
  11. Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors

    Background

    Enfortumab vedotin (EV), an antibody–drug conjugate targeting Nectin-4, has been used for patients with metastatic urothelial carcinoma...

    Taizo Uchimoto, Shuya Tsuchida, ... Haruhito Azuma in Targeted Oncology
    Article 28 March 2024
  12. Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study

    Objectives

    Pulmonary sarcomatoid carcinoma (PSC) is a rare histological type of non-small cell lung cancer (NSCLC). There are no specific treatment...

    Feng Wang, **angyang Yu, ... Shuku Liu in BMC Pulmonary Medicine
    Article Open access 15 July 2023
  13. Cryopreventive temperatures prior to chemotherapy

    The superiority of oral cryotherapy (OC) for prevention of chemotherapy-induced oral mucositis (OM) has been demonstrated in several trials. In...

    A. Ibrahim, E. Camci, ... J. Walladbegi in Medical Oncology
    Article Open access 14 April 2023
  14. Prognostic significance of adjuvant chemotherapy in stage I–II endometrial carcinoma patients who underwent lymphadenectomy

    Background

    Endometrial carcinoma, the most common gynecologic carcinoma, has an excellent prognosis post-surgery when diagnosed early. The role of...

    Jiro Suzuki, Hiroshi Tanabe, ... Aikou Okamoto in International Journal of Clinical Oncology
    Article 19 June 2024
  15. Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a sco** review

    Background

    Chemotherapy-related cardiotoxicity is a significant concern because it is a major cause of morbidity. This study aimed to provide in-depth...

    Hyunjoo Kim, Bomi Hong, ... Jeongok Park in Systematic Reviews
    Article Open access 27 June 2024
  16. Mixed neuroendocrine–non-neuroendocrine neoplasm of the bile duct with long-term prognosis after neoadjuvant chemotherapy

    A 74-year-old man with obstructive jaundice presented with a thickened distal bile duct wall. A transpapillary forceps biopsy revealed an...

    Shinya Nakamura, Masahiro Serikawa, ... Shiro Oka in Clinical Journal of Gastroenterology
    Article Open access 24 May 2024
  17. Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes

    Purpose

    Sleep problems are commonly reported by cancer survivors; however, knowledge of the impact of chemotherapy-induced peripheral neurotoxicity...

    Fawaz Mayez Mahfouz, Tiffany Li, ... Susanna B. Park in Supportive Care in Cancer
    Article Open access 20 December 2023
  18. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer

    Purpose

    Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect of neurotoxic chemotherapy. Exercise activates neuromuscular...

    Kirin Saint, David Nemirovsky, ... Ting Bao in Breast Cancer Research and Treatment
    Article 07 May 2024
  19. Second-Line Chemotherapy in Gastric Cancer: a Retrospective Study

    Second-line chemotherapy is recommended for patients who have disease progression after first-line chemotherapy and have a good performance status....

    Serkan YILDIRIM, Ahmet Özveren in Indian Journal of Surgical Oncology
    Article 05 January 2023
  20. Influence of Neoadjuvant Immunotherapy–Chemotherapy on Perioperative Outcomes in Locally Advanced Esophageal Adenocarcinoma

    Background

    This study evaluated the perioperative outcomes for patients who had locally advanced esophageal adenocarcinoma (EAC) treated with...

    Yehonatan Nevo, James Tankel, ... Lorenzo Ferri in Annals of Surgical Oncology
    Article 26 March 2024
Did you find what you were looking for? Share feedback.